Ftse Mib
33.896,19
-1,17%
DAX
18.016,43
-0,64%
S&P 500
5.094,34
-0,43%
NASDAQ Composite
15.936,39
-0,29%
Bitcoin
61.233,06
-4,08%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rocket Pharmaceuticals Inc (RCKT) Rocket Pharmaceuticals Inc (RCKT) Notizie

Rocket Pharmaceuticals Inc

RCKT
21,79
-0,06 (-0,27%)
Ultimo aggiornamento: 16:52:33
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/4/202412:00BWRocket Pharmaceuticals Announces European Medicines Agency..
26/3/202421:01BWRocket Pharmaceuticals Announces Appointment of Aaron Ondrey..
05/3/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202421:54EDGAR2Form 144 - Report of proposed sale of securities
29/2/202420:59EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:37EDGAR2Form 8-K - Current report
26/2/202422:01BWRocket Pharmaceuticals Reports Fourth Quarter and Full Year..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:28EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
16/2/202422:37EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:31EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:26EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:22EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:37EDGAR2Form 8-K - Current report
13/2/202413:00BWRocket Pharmaceuticals Announces Update on FDA Review..
29/1/202421:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202421:16EDGAR2Form 144 - Report of proposed sale of securities
02/1/202422:01BWRocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan..
13/12/202322:05EDGAR2Form 8-K - Current report
13/12/202302:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202313:00BWRocket Pharmaceuticals Appoints R. Keith Woods to Board of..
17/11/202301:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202301:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202301:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202321:28EDGAR2Form 144 - Report of proposed sale of securities
16/11/202321:21EDGAR2Form 144 - Report of proposed sale of securities
16/11/202321:21EDGAR2Form 144 - Report of proposed sale of securities
07/11/202322:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:04BWRocket Pharmaceuticals Reports Third Quarter 2023 Financial..
25/10/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202321:19EDGAR2Form 144 - Report of proposed sale of securities
19/10/202313:00BWRocket Pharmaceuticals Announces Presentations Highlighting..
10/10/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202303:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:05EDGAR2Form 8-K - Current report
02/10/202313:00BWRocket Pharmaceuticals Announces FDA Acceptance of Biologics..
26/9/202322:01BWRocket Pharmaceuticals to Participate in the Chardan 7th..
20/9/202322:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Apertura: 21,57 Min: 21,44 Max: 21,98
Chiusura: 21,85

La tua Cronologia

NASDAQ
RCKT
Rocket Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network